Short- vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Radiology

Background:

• Magnetoliposomes are emerging as potential contrast agents for magnetic resonance (MR) imaging.
• Optimizing their circulation time and relaxivity is crucial for effective bone marrow imaging.
• Polyethylene glycol (PEG)ylation is a common strategy to prolong nanoparticle circulation.

Purpose of the Study:

• To evaluate the relaxation enhancement and biodistribution of short- vs. long-circulating magnetoliposomes for MR imaging of bone marrow.
• To compare magnetoliposomes with and without PEGylation (ML-PEG vs. ML) as bone marrow contrast agents.

Main Methods:

• Preparation of 40 nm magnetoliposomes with and without PEGylation (ML-PEG, ML).
• Characterization of relaxivity (R1, R2) at 1.5 T and 37°C.
• Intravenous administration in young and adult Sprague-Dawley rats (100 pmol Fe/kg).
• Assessment of blood half-life and biodistribution via MR imaging.

Main Results:

• PEGylation enhanced T2 relaxivity by 10-15% (R2 = 240 s⁻¹mM⁻¹).
• PEGylated magnetoliposomes exhibited a significantly longer blood half-life (53.2 ± 13.2 min) compared to non-PEGylated ones (7.4 ± 0.4 min).
• Both ML and ML-PEG showed pronounced bone marrow uptake, visualized using fast spin-echo T2-weighted imaging.
• Optimal contrast enhancement allowed depiction of age-related red to yellow marrow conversion.

Conclusions:

• PEGylated magnetoliposomes offer improved circulation kinetics for bone marrow MR imaging.
• Magnetoliposomes effectively enhance contrast in bone marrow, visualizing normal aging processes.
• Further research is needed to explore their potential in differentiating abnormal marrow conditions.